Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous...
51 insider purchases on record · latest filing 2025-11-05.
Insiders have also filed 2 sale transactions at PSTV.